Reactivation of Ocular Toxoplasmosis in Immunosuppressed Neurosarcoidosis: A Case Report

Objective: To report a case of ocular toxoplasmosis reactivation in a patient with neurosarcoidosis undergoing immunosuppressive therapy. Methods: Case report and literature review. Results: A 34-year-old male with neurosarcoidosis, treated with Infliximab and Mycophenolate Mofetil, presented with sudden visual decline in his left eye. Multimodal imaging revealed active chorioretinitis. Serological tests showed elevated Toxoplasma IgG levels with normal IgM levels. Treatment with oral corticosteroids and antibiotics led to significant improvements in vitreous turbidity and lesion inactivity at follow-up, despite unchanged visual acuity. Conclusions: This case highlights the risk of toxoplasmosis reactivation in immunosuppressed sarcoidosis patients. It emphasizes the importance of considering ocular toxoplasmosis even with normal IgM levels, and demonstrates the value of multimodal imaging in diagnosis and follow-up.

Authors

Institutions

Publication Details

Journal
Journal of Clinical & Translational Ophthalmology
Published
2025-04-21
DOI
https://doi.org/10.3390/jcto3020007
Primary Topic
Sarcoidosis and Beryllium Toxicity Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Reactivation of Ocular Toxoplasmosis in Immunosuppressed Neurosarcoidosis: A Case Report

Silvana Guerriero, Mariapia Laterza, Giacomo Boscia, Pasquale Viggiano et al.
Journal of Clinical & Translational Ophthalmology
Sarcoidosis and Beryllium Toxicity Research
article

Reactivation of Ocular Toxoplasmosis in Immunosuppressed Neurosarcoidosis: A Case Report

Silvana Guerriero, Mariapia Laterza, Giacomo Boscia, Pasquale Viggiano, Francesco Boscia, Alba Chiara Termite, Antonio Salvelli, Enrico Settimo
article en

Abstract

Objective: To report a case of ocular toxoplasmosis reactivation in a patient with neurosarcoidosis undergoing immunosuppressive therapy. Methods: Case report and literature review. Results: A 34-year-old male with neurosarcoidosis, treated with Infliximab and Mycophenolate Mofetil, presented with sudden visual decline in his left eye. Multimodal imaging revealed active chorioretinitis. Serological tests showed elevated Toxoplasma IgG levels with normal IgM levels. Treatment with oral corticosteroids and antibiotics led to significant improvements in vitreous turbidity and lesion inactivity at follow-up, despite unchanged visual acuity. Conclusions: This case highlights the risk of toxoplasmosis reactivation in immunosuppressed sarcoidosis patients. It emphasizes the importance of considering ocular toxoplasmosis even with normal IgM levels, and demonstrates the value of multimodal imaging in diagnosis and follow-up.

Journal of Clinical & Translational OphthalmologyVol. 3(2)
University of Bari Aldo Moro (IT)
Openalex Percentile: Top 90%
Sarcoidosis and Beryllium Toxicity Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.